
### [MONDO:0016046](http://purl.obolibrary.org/obo/MONDO_0016046)
**Label:** familial clubfoot with or without associated lower limb anomalies

**Subclasses:** [MONDO:0017383](http://purl.obolibrary.org/obo/MONDO_0017383) (familial clubfoot due to PITX1 point mutation), [MONDO:0007342](http://purl.obolibrary.org/obo/MONDO_0007342) (clubfoot), [MONDO:0013329](http://purl.obolibrary.org/obo/MONDO_0013329) (familial clubfoot due to 17q23.1q23.2 microduplication), [MONDO:0017382](http://purl.obolibrary.org/obo/MONDO_0017382) (familial clubfoot due to 5q31 microdeletion), 

**Mapped go classes:** [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0048625](http://purl.obolibrary.org/obo/GO_0048625) (myoblast fate commitment), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0014707](http://purl.obolibrary.org/obo/GO_0014707) (branchiomeric skeletal muscle development), [GO:0001190](http://purl.obolibrary.org/obo/GO_0001190) (transcriptional activator activity, RNA polymerase II transcription factor binding), [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), 

**Class expressions from DL-Learner:**

- [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis) 62.50%
- [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis) 62.50%
- [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development) 62.50%
- [GO:0014707](http://purl.obolibrary.org/obo/GO_0014707) (branchiomeric skeletal muscle development) 62.50%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 62.50%
- [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis) and [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis) 62.50%
- [GO:0035113](http://purl.obolibrary.org/obo/GO_0035113) (embryonic appendage morphogenesis) and [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis) 62.50%
- [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis) and [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis) 62.50%
- Thing 51.28%
- [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis) 47.86%
- [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis) 47.86%
- [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development) 47.86%
- [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis) and [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis) 47.86%
- [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis) and [GO:0035113](http://purl.obolibrary.org/obo/GO_0035113) (embryonic appendage morphogenesis) 47.86%
- [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development) and [GO:0061061](http://purl.obolibrary.org/obo/GO_0061061) (muscle structure development) 47.86%


